Clinical Trials on Small for Gestational Age in Taiwan
Total 42 results
-
GeneScience Pharmaceuticals Co., Ltd.Children's Hospital of Fudan University; The First Hospital of Jilin University and other collaboratorsUnknownSmall for Gestational Age InfantChina
-
Chao-Hui, LeeNational Taipei University of Nursing and Health SciencesRecruitingHealth Knowledge, Attitudes, Practice | Gestational Age and Weight ConditionsTaiwan
-
China Medical University HospitalUnknownCondition 1. Children With ALL Are Still Alive and the Age of 18 Years of Age. | Condition 2. Has Been Completed to Guide the Treatment Regimen Were in Remission. | Condition 3. Caregiver Can or Taiwanese Language Communicator.Taiwan
-
National Yang Ming UniversityUnknown
-
National Yang Ming UniversityUnknownHealth Service for the AgedTaiwan
-
SanofiRecruiting
-
National Taiwan University HospitalUnknown
-
Xiamen Amoytop Biotech Co., Ltd.Tongji HospitalCompletedTurner Syndrome | Small for Gestational Age | Idiopathic Short StatureChina
-
Chang Gung Memorial HospitalCompletedSmall and/or Deep Lung TumorTaiwan
-
National Taiwan University HospitalRecruitingStroke | Magnetic Resonance Imaging | Fabry Disease | Cerebral Small Vessel Diseases | Cadasil | HTRA1-Related Autosomal Dominant Cerebral Angiopathy | COL4A1-Related Brain Small Vessel Disease With Haemorrhage | Next-generation SequencingTaiwan
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCUnited States, Spain, Taiwan, Japan, Italy
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
Mackay Memorial HospitalRecruiting
-
National Taiwan University HospitalRecruitingCerebral Amyloid Angiopathy | Intracerebral HemorrhageTaiwan
-
Chang Gung Memorial HospitalSanofiUnknown
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Non-Small Cell Lung Cancer | EGFR Exon20 Insertion MutationsChina
-
National Taiwan University HospitalCompletedAlzheimer Disease | Intracranial Hemorrhages | Cerebral Amyloid AngiopathyTaiwan
-
Chang Gung Memorial HospitalRecruitingFabry DiseaseTaiwan
-
National Taiwan University HospitalRecruitingAlzheimer Disease | Intracranial Hemorrhages | Cerebral Amyloid AngiopathyTaiwan
-
CStone PharmaceuticalsPfizerActive, not recruitingAdvanced or Metastatic ROS1-Positive Non-Small Cell Lung CancerChina
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerKorea, Republic of, Italy, Poland, Malaysia, Taiwan, Thailand, United States, France, Netherlands, Philippines, Canada, Singapore, Spain, Turkey, Australia, Belgium, Israel
-
4D Molecular TherapeuticsActive, not recruiting
-
National Taiwan University HospitalNational Cheng-Kung University HospitalUnknownMELAS Syndrome | Noninsulin-dependent Diabetes Mellitus With DeafnessTaiwan
-
AkesoNot yet recruitingLocally Advanced or Metastatic NSCLCChina
-
AstraZenecaDaiichi SankyoRecruitingAdvanced or Metastatic NSCLCUnited States, Taiwan, Italy, Spain, Poland, Japan, Belgium, Turkey, France, Korea, Republic of
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
AstraZenecaParexelRecruitingAdvanced or Metastatic Non-Small Cell Lung CancerChina, Netherlands, Korea, Republic of, Italy, Spain, Canada, Hungary, Japan, Argentina, France, United States, Taiwan, Poland, Serbia, United Kingdom, Hong Kong, Brazil, Germany, Belgium, Romania, India, Ireland, Australia
-
AstraZenecaDaiichi SankyoRecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina, Korea, Republic of, Germany, Italy, Poland, Belgium, Mexico, Turkey, Spain, France, United States, Canada, Taiwan, Brazil, Austria, Hong Kong, India, Japan, Netherlands, Denmark
-
Janssen Research & Development, LLCActive, not recruitingAdvanced or Metastatic Non-small Cell Lung CancerItaly, United States, Germany, Japan, China, Korea, Republic of, Israel, Portugal, Taiwan, Thailand, Malaysia, United Kingdom, Australia, Turkey, Poland, Spain, Brazil, Canada, Argentina, France
-
National Taiwan University HospitalUnknownHypertension | Diabetes | Dementia | Alzheimer Disease | Fabry Disease | Dry Eye Syndrome | Metabolic Disease | Healthy Individuals | Ocular Rosacea | Limbal Insufficiency | Phlyctenulosis | Graft Versus Host Disease in EyeTaiwan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedStage IV or Recurrent Non-Small Cell Lung CancerUnited States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more
-
Amicus TherapeuticsCompletedFabry DiseaseJapan, Taiwan, Turkey, United States, Brazil
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyTerminatedFabry DiseaseAustria, Brazil, France, United States, Argentina, Belgium, Canada, Finland, Hungary, Norway, Poland, Spain, Taiwan, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
AstraZenecaRecruitingCervical Cancer | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Biliary Cancer | Additional Indications Below for Module 4 and 5 | Small Cell Lung Cancer Only in Module 5Canada, Spain, China, Korea, Republic of, Italy, Poland, United States, Australia, United Kingdom, Japan, Hungary, Russian Federation, Czechia
-
Sangamo TherapeuticsActive, not recruitingFabry DiseaseUnited States, United Kingdom, Taiwan, Australia, Germany, Italy, Canada
-
SanofiRecruitingFabry DiseaseItaly, United States, Austria, China, Czechia, Denmark, France, Germany, Greece, Japan, Korea, Republic of, Netherlands, Norway, Spain, Taiwan, Turkey, United Kingdom, Canada, Poland
-
Genzyme, a Sanofi CompanyRecruitingFabry DiseaseCroatia, United States, Argentina, Australia, Belgium, Bulgaria, Canada, Germany, Hong Kong, India, Indonesia, Korea, Republic of, Kuwait, Malaysia, Philippines, Poland, Romania, Singapore, Slovakia, Taiwan, Thailand, United Kingdom, Vietn... and more
-
SanofiRecruitingFabry DiseaseChina, Finland, Germany, Norway, United Kingdom, United States, Denmark, Austria, Greece, Romania, Argentina, Brazil, Canada, Japan, Mexico, Poland, Italy, France, Turkey, Australia, Switzerland
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Nasopharyngeal Carcinoma | Adenoid Cystic Carcinoma | Transitional Cell Carcinoma | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Chordoma | Gestational Trophoblastic Tumor | Pseudomyxoma Peritonei | Cervical Adenocarcinoma | Vaginal Adenocarcinoma | Vaginal Squamous Cell... and other conditionsUnited States, Guam